Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +48.99%
#3 DOVU DOVU +48.23%
#4 Velvet Velvet +40.95%
#5 Black Phoenix Black Phoenix +34.26%
#6 Cross Cross +20.75%
#7 Cysic Cysic +18.58%
#8 Perle Perle +18.18%
#9 Ο„emplar Ο„emplar +16.67%
#10 Ribbita by Virtuals Ribbita by Virtuals +15.67%
Coin of the day
Glidr Glidr
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Kedudukan dalam Saham #38583
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Harga Saham
$1.52
Modal Pasaran
$906.74K
Perubahan (1 hari)
0.58%
Perubahan (1 tahun)
-88.60%
Negara
US
Perdagangan Enveric Biosciences, Inc. (ENVB)

Kategori

Healthcare
Sejarah hasil dividen untuk Enveric Biosciences, Inc. (ENVB)
Hasil dividen (TTM) bagi Enveric Biosciences, Inc. (simbol saham: ENVB) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Enveric Biosciences, Inc. (ENVB) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE